Dysfunction of the carnitine cycle in tumor progression

Area of Science:

• Biochemistry
• Oncology
• Metabolic pathways

Background:

• The carnitine cycle transports fatty acids into mitochondria for energy production.
• Altered carnitine cycle enzymes and proteins are observed in various tumors.
• Carnitine cycle dysfunction affects tumor progression via oxidative stress, inflammation, and metabolic flexibility.

Purpose of the Study:

• To review the role of the carnitine cycle in tumor progression.
• To highlight carnitine cycle dysfunction in malignant tumors.
• To explore therapeutic strategies targeting the carnitine cycle in cancer.

Main Methods:

• Literature review of studies on carnitine and tumors.
• Analysis of carnitine cycle alterations in cancer.
• Examination of therapeutic approaches targeting the carnitine cycle.

Main Results:

• Carnitine cycle abnormalities are linked to tumorigenesis and progression.
• Dysfunctional carnitine cycle influences tumor's oxidative and inflammatory state.
• Altered metabolic flexibility in tumors is associated with carnitine cycle disruption.

Conclusions:

• Carnitine cycle dysfunction is a significant factor in tumor progression.
• Targeting the carnitine cycle presents potential therapeutic avenues for cancer.
• Further research into carnitine's role in tumors is warranted.